G6PD Deficiency: Clinical Trials

4 trials for G6PD Deficiency, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting, 1 terminated, 1 unknown. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Completed 1, Recruiting 1, Terminated 1, Unknown 1

Follow G6PD Deficiency: new trials by email Literature Review of G6PD Deficiency trials Research Report on G6PD Deficiency

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Primaquine for Vivax Malaria in G6PD Intermediate and Deficient Cases.
Patients with G6PD enzyme activities between 30 and <70% of the AMM will be treated with schizontocidal treatment plus high dose primaquine 1mg/kg/day for 7 days, Patients with G6PD enzyme activities <30% of the AMM will be treated with schizontocidal treatment plus 8 weekly primaquine (0.75mg/kg dose). - Vivax Malaria, G6PD Deficiency
Phase 4RecruitingMenzies School of Health Research1002024-05-172026-03-12
Safety and Efficacy of Aspirin in Stroke Patients With Glucose-6-phosphate Dehydrogenase Deficiency (SAST)
Aspirin, Clopidogrel - G6PD Deficiency, Stroke
Phase 4UnknownFirst Affiliated Hospital, Sun Yat-Sen University4402020-01-222022-03-16
Assessing a Risk Model for G6PD Deficiency
primaquine, chloroquine + primaquine - Malaria, Vivax, G6PD Deficiency
Phase 4TerminatedPATH542018-05-072021-11-12
Safety and Tolerability of Low Dose Primaquine
Dihydroartemisinin piperaquine (DHA PP), Primaquine - Malaria, Falciparum, G6PD Deficiency
Phase 4CompletedMalaria Consortium1092014-10-012016-08-23

Narrower conditions

Glucosephosphate Dehydrogenase Deficiency (4)  ·  Malaria, Vivax (2)  ·  Hemolysis (1)  ·  Ischemic Stroke (1)  ·  Malaria, Falciparum (1)  ·  Stroke (1)

Broader conditions

Anemia (4)  ·  Anemia, Hemolytic (4)  ·  Anemia, Hemolytic, Congenital (4)  ·  Carbohydrate Metabolism, Inborn Errors (4)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4)  ·  Genetic Diseases, Inborn (4)  ·  Hematologic Diseases (4)  ·  Hemic and Lymphatic Diseases (4)  ·  Metabolic Diseases (4)  ·  Metabolism, Inborn Errors (4)  ·  Nutritional and Metabolic Diseases (4)  ·  Infections (3)  ·  Malaria (3)  ·  Mosquito-Borne Diseases (3)  ·  Parasitic Diseases (3)

Interventions

Primaquine (3)  ·  Aspirin (1)  ·  Chloroquine (1)  ·  Clopidogrel (1)

Sponsors

First Affiliated Hospital, Sun Yat-Sen University (1)  ·  Malaria Consortium (1)  ·  Menzies School of Health Research (1)  ·  PATH (1)

Countries

Brazil (1)  ·  Cambodia (1)  ·  China (1)  ·  Ethiopia (1)  ·  Papua New Guinea (1)  ·  Thailand (1)

Top investigators

Dysoley Lek, MD (1)  ·  Jinsheng Zeng, MD,PhD (1)

Results publications

PMID 30871496, PMID 32179526